ArticleFrontiers in immunology2022

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy.

He Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.